Log In
Print this Print this

Endothelin receptor antagonist (ERA)

  Manage Alerts
Collapse Summary General Information
Company Actelion Ltd.
DescriptionEndothelin receptor antagonist
Molecular Target Endothelin receptor
Mechanism of ActionEndothelin receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHypertension
Indication DetailsTreat essential hypertension
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today